The Pharmaceutical Journal
Vol 277 No 7421 p417
7 October 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Three new pharmaceutical products awarded honour

Three UK Prix Galien gold medals for pharmaceutical innovation have been awarded to new medicines this year. The winners are: alglucosidase alfa (Myozyme; Genzyme), an orphan drug for the treatment of Pompe disease; Rotarix (GlaxoSmithKline), a vaccine for the prevention of rotavirus infection; and omalizumab (Xolair; Novartis), an add-on therapy for patients with severe persistent allergic asthma.